Nivolumab,Ipilimumab
BMS
['biomarker', 'prevail,(-prevailing),(-prevailed)', 'urothelial', 'marker ']
good question i welcome everyone to our poster assessing pdl1 expression in 1l advanced urothelial ca tomorrow prevail biomarker study with real world data agree with we need to assess additional biomarkers #esmo22 
Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine